Condition: Fractures, Bone · Nonunion of Fracture · Fractures, Open · Sponsor: LifeNet Health
Prospective registry and retrospective data collection study to assess the efficacy and safety of Vivigen Cellular Bone Matrix (Vivigen) in orthopaedic trauma patients who require bone grafting in the acute, delayed, non-union fracture as well as use in fusion procedure settings.
This description comes directly from the study's public registry record.
Barry Saxton, P.A.-C. · 404 314 4903 · barry_saxton@lifenethealth.org
Alyce Jones, Ph.D. · alyce_jones@lifenethealth.org
Always discuss trial participation with your own doctor first.
| OrlandoHealth | Orlando, Florida, United States | Recruiting |
| RWJBarnabas Health | Jersey City, New Jersey, United States | Not Yet Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
| Sentara Hospitals | Norfolk, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04299022